Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(50%)
Results Posted
200%(2 trials)

Phase Distribution

Ph phase_2
2
33%
Ph early_phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)

Detailed Status

Recruiting2
Withdrawn2
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

active_not_recruiting117%
recruiting233%
withdrawn233%
completed117%

Recent Activity

3 active trials
Showing 5 of 6
completednot_applicable

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

NCT04816591
active_not_recruitingphase_2

Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

NCT02919683
recruitingnot_applicable

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

NCT06335719
withdrawnphase_2

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

NCT03517995
recruitingphase_4

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

NCT04205916
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04816591Not Applicable

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

Completed
NCT02919683Phase 2

Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

Active Not Recruiting
NCT06335719Not Applicable

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

Recruiting
NCT03517995Phase 2

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Withdrawn
NCT04205916Phase 4

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

Recruiting
NCT02419170Early Phase 1

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6